Wilma D.J. Verhagen-Kamerbeek

From biomarkers to medical tests: The changing landscape of test evaluation

Andrea R. Horvath, Sarah J. Lord, Andrew St John et al. · Clinica Chimica Acta · 2013 · 196 citations

Pharmacy, Biomedical Informatics, Health Informatics +14

Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia

Xu-ming Bian, Arijit Biswas, Xianghuang Huang et al. · Hypertension · 2019 · 135 citations · Full text

Medicine, Maternal Health, Obstetrics +14

Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol

Martin Hund, Deirdre Allegranza, Maria Schoedl et al. · BMC Pregnancy and Childbirth · 2014 · 75 citations · Full text

Medicine, Maternal Health, Obstetrics +17

Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia

Evelyn Klein, Dietmar Schlembach, A Ramoni et al. · PLoS ONE · 2016 · 72 citations · Full text

Medicine, Maternal Health, Obstetrics +9

Biomarker development targeting unmet clinical needs

Phillip J. Monaghan, Sarah J. Lord, Andrew St John et al. · Clinica Chimica Acta · 2016 · 58 citations

Pharmacy, Clinical Sciences, Translational Sciences +13